A Patient with Multiple Myeloma who Developed Severe Myoclonus after Stem Cell TransplantationSebnem Izmir Güner1*, Merve Pamukçuoglu2 and Gülsan Sucak3
- *Corresponding Author:
- Sebnem Izmir Güner
Department of Hematology, Istanbul kemerburgaz University
Medicalpark Bahçelievler Hospital, Istanbul-Turkey
Tel: 0090 2124831206
E-mail: [email protected]
Received date: October 11, 2015; Accepted date: October 27, 2015; Published date: November 10, 2015
Citation: Guner SI, Pamukçuoglu M, Sucak G (2015) A Patient with Multiple Myeloma who Developed Severe Myoclonus after Stem Cell Transplantation . J Leuk 3:193. doi:10.4172/2329-6917.1000193
Copyright: © 2015 Guner SI, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
There are various neurologic manifestations of Multiple Myeloma (MM) seen either at presentation or as a complication of various anti- myeloma agents administered during the course of the disease. These neurologic complications might occasionally be challenging to diagnose and treat. Peripheral nervous system is more commonly affected and peripheral neuropathy is the most common form of neurologic complications seen in MM. Here we report a gentleman with MM on regular renal replacement therapy developed severe myoclonus 3 days status post autologous stem cell (ASCT). Besides MM, he had Hypertension and Diabetes Mellitus as to his renal failure. He was also suffering from neuropathy for which gabapentin was commenced.